Publication Citations

Zdroj: Web Of Science

webofscience

 i[1]

 

GESUNDHEIT, B., J.P. ROSENZWEIG, D. NAOR, B. LERER, D.A. ZACHOR a Václav PROCHÁZKA. Immunological and autoimmune considerations of Autism Spectrum Disorders. Journal of autoimmunity. 2013, vol. 44, no. August, p. 1-7. ISSN 0896-8411. (7.018 – IF2013).  
Cit.[1] Samsam, M., Ahangari, R., Naser, S.A.Pathophysiology of autism spectrum disorders: Revisiting gastrointestinal involvement and immune imbalance(2014) World Journal of Gastroenterology, 20 (29), pp. 9942-9951.  WOS
Cit.[2] Selmi, C.Autoimmunity in 2013(2014) Clinical Reviews in Allergy and Immunology, 47 (1), pp. 100-109. WOS
 Cit.[3] The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophagesBy: Siniscalco, Dario; Bradstreet, James Jeffrey; Cirillo, Alessandra; et al.

JOURNAL OF NEUROINFLAMMATION Volume: 11Article Number: 78Published: APR 17 2014

WOS
Cit.[4]  Brain autoantibodies in autism spectrum disorderBy: Elamin, Nadra E.; AL-Ayadhi, Laila Y.

BIOMARKERS IN MEDICINE Volume: 8Issue: 3Pages: 345-352Published: MAR 2014

WOS
Cit.[5]  Using genetic findings in autism for the development of new pharmaceutical compoundsBy: Vorstman, Jacob A. S.; Spooren, Will; Persico, Antonio M.; et al.

PSYCHOPHARMACOLOGY Volume: 231Issue: 6Pages: 1063-1078Published: MAR 2014

WOS
Cit.[6]  Activating KIR molecules and their cognate ligands prevail in children with a diagnosis of ASD and in their mothersBy: Guerini, Franca R.; Bolognesi, Elisabetta; Chiappedi, Matteo; et al.

BRAIN BEHAVIOR AND IMMUNITY Volume: 36 Pages: 54-60 Published: FEB 2014

WOS
Cit.[7]  A new methodology of viewing extra-axial fluid and cortical abnormalities in children with autism via transcranial ultrasonographyBy: Bradstreet, James Jeffrey; Pacini, Stefania; Ruggiero, Marco

FRONTIERS IN HUMAN NEUROSCIENCE Volume: 7Article Number: 934Published: JAN 15 2014

WOS
Cit.[8]  Immune dysregulation in autism spectrum disorderBy: Noriega, Daniela Briceno; Savelkoul, Huub F. J.

EUROPEAN JOURNAL OF PEDIATRICS Volume: 173Issue: 1Pages: 33-43Published: JAN 2014

WOS
Cit.[9]  Rossignol, D.A., Frye, R.E.Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism(2014) Frontiers in Physiology, 5 APR, art. no. Article 150, . SCOPUS
Cit.[10]  van Elst, K., Bruining, H., Birtoli, B., Terreaux, C., Buitelaar, J.K., Kas, M.J.Food for thought: Dietary changes in essential fatty acid ratios and the increase in autism spectrum disorders(2014) Neuroscience and Biobehavioral Reviews, 45, pp. 369-378. SCOPUS
Cit.[11]  Bronson, S.L., Bale, T.L.Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment(2014) Endocrinology, 155 (7), pp. 2635-2646. SCOPUS
i[2]  ROUBEC, Martin, Martin KULIHA, Václav PROCHÁZKA, Jan KRAJČA, Daniel CZERNÝ, Tomáš JONSZTA, A. KRAJINA, D. ŠAŇÁK, K. LANGOVÁ, R. HERZIG a David ŠKOLOUDÍK. <A >Controlled trial of revascularization in acute stroke. Radiology. 2013, vol. 266, no. 3, p. 871-878. ISSN 0033-8419. (6.214 – IF2013).  
 Cit.[1] Mechanical Thrombectomy with Stent Retrievers in Acute Ischemic StrokeBy: Hausegger, Klaus A.; Hauser, Michael; Kau, Thomas

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY Volume: 37Issue: 4Pages: 863-874Published: AUG 2014

WOS
Cit.[2]  Society of Interventional Radiology Position Statement on Endovascular Acute Ischemic Stroke InterventionsBy: Sacks, David; Connors, J. J. (Buddy), III; Black, Carl M.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY Volume: 24Issue: 9Pages: 1263-1266Published: SEP 2013

WOS
Cit.[3]  Impact of Onset-to-Reperfusion Time on Stroke Mortality A Collaborative Pooled AnalysisBy: Mazighi, Mikael; Chaudhry, Saqib A.; Ribo, Marc; et al.

CIRCULATION Volume: 127Issue: 19Pages: 1980-1985Published: MAY 14 2013

WOS
Cit.[4] Mortimer, A.M., Bradley, M.D., Renowden, S.A.Endovascular therapy in hyperacute ischaemic stroke: History and current status(2013) Interventional Neuroradiology, 19 (4), pp. 506-518. SCOPUS
Cit.[5] Zhou, C., Zhang, P.-L.Study of transcranial Doppler flow grades of thrombolysis in brain ischemia in patients with acute middle cerebral artery occlusion after alteplase treatment(2013) Chinese Journal of Contemporary Neurology and Neurosurgery, 13 (9), pp. 792-796. SCOPUS
i[3]  HALLIDAY, A., Tomáš HRBÁČ, Martin KULIHA, Václav PROCHÁZKA, Martin ROUBEC a David ŠKOLOUDÍK. Status update and interim results from the asymptomatic carotid surgery trial-2 (ACST-2). European journal of vascular and endovascular surgery. 2013, vol. 46, no. 5, p. 510-518. ISSN 1078-5884.
Cit.[1] Ocular Defects as Surrogate End-Points in Trials Comparing Carotid Endarterectomy and StentingBy: Giannoukas, A. D.; Paraskevas, K. I.; Bulbulia, R.; et al.

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY Volume: 48Issue: 1Pages: 105-106Published: JUL 2014

WOS
Cit.[2] Paraskevas, K.I., Abbott, A.L., Veith, F.J.Optimal management of patients with symptomatic and asymptomatic carotid artery stenosis: Work in progress(2014) Expert Review of Cardiovascular Therapy, 12 (4), pp. 437-441. SCOPUS
i[4]  HRBÁČ, Tomáš, V. BENEŠ, Pavel ŠIRŮČEK, Tomáš JONSZTA, R. HERZIG, Václav PROCHÁZKA a David ŠKOLOUDÍK. Safety and efficacy of surgical treatment of carotid stump syndrome: pilot study. Annals of Vascular surgery. 2012, vol. 26, no. 6, p. 797-801. ISSN 0890-5096.
Cit.[1] Contralateral microemboli following carotid artery stenting in patients with a contralateral internal carotid artery occlusionBy: Casey, Kevin; Hitchner, Elizabeth; Lane, Barton; et al.

Conference: 40th Annual Meeting of the Society-for-Clinical-Vascular-Surgery (SCVS)Location: Las Vegas, NVDate: MAR 13-17, 2012
Sponsor(s): Soc Clin Vasc Surg

JOURNAL OF VASCULAR SURGERY Volume: 58 Issue: 3 Pages: 794-797 Published: SEP 2013

WOS
i[5]  BAR, Michal, R. MIKULÍK, Tomáš JONSZTA, A. KRAJINA, Martin ROUBEC, David ŠKOLOUDÍK a Václav PROCHÁZKA. Diagnosis of recanalization of the intracranial artery has poor inter-rater reliability. American journal of neuroradiology. 2012, vol. 33, no. 5, p. 972-974. ISSN 0195-6108.
Cit.[1] Inter- and Intraobserver Agreement in Scoring Angiographic Results of Intra-Arterial Stroke TherapyBy: Gaha, M.; Roy, C.; Estrade, L.; et al.

AMERICAN JOURNAL OF NEURORADIOLOGY Volume: 35Issue: 6Pages: 1163-1169Published: JUN 2014

WOS
Cit.[2] Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke A Consensus StatementBy: Zaidat, Osama O.; Yoo, Albert J.; Khatri, Pooja; et al.

Group Author(s): Cerebral Angiographic Revasc; STIR Revascularization Working Grp; STIR Thrombolysis Cerebral

STROKE Volume: 44Issue: 9Pages: 2650-2663Published: SEP 2013

WOS
Cit.[3] Clarifying Differences Among Thrombolysis in Cerebral Infarction Scale Variants Is the Artery Half Open or Half Closed?By: Suh, Sang Hyun; Cloft, Harry J.; Fugate, Jennifer E.; et al.

STROKE Volume: 44Issue: 4Pages: 1166-+Published: APR 2013

WOS
Cit.[4] Endovascular Treatment of an Ischemic Cerebrovascular EventBy: Skoloudik, D.; Kuliha, M.; Jonszta, T.; et al.

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE Volume: 75Issue: 6Pages: 669-682Published: 2012

WOS
i[6]  ŠAŇÁK, D., Martin KULIHA, R. HERZIG, Martin ROUBEC, David ŠKOLOUDÍK, J. ZAPLETALOVÁ, M. KÖCHER, M. KRÁL, T. VEVERKA, E. ČECHÁKOVÁ, A. BÁRTKOVÁ, Václav PROCHÁZKA a P. KAŇOVSKÝ. Prior use of antiplatelet therapy can be associated with a higher chance for early recanalization of the occluded middle cerebral artery in acute stroke patients treated with intravenous thrombolysis. European Neurology. 2012, vol. 67, no. 1, p. 52-56. ISSN 0014-3022.
Cit.[1] Risks and Benefits of Early Antithrombotic Therapy after Thrombolytic Treatment in Patients with Acute StrokeBy: Amaro, Sergio; Llull, Laura; Urra, Xabier; et al.

PLOS ONE Volume: 8Issue: 8Article Number: e71132Published: AUG 8 2013

WOS
Cit.[2] Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatmentBy: Diener, Hans-Christoph; Foerch, Christian; Riess, Hanno; et al.

LANCET NEUROLOGY Volume: 12Issue: 7Pages: 677-688Published: JUL 2013

WOS
Cit.[3] Thrombolytic Agents for Acute Ischaemic Stroke Treatment: The Past, Present and FutureBy: Balami, Joyce S.; Chen, Ruoli; Sutherland, Brad A.; et al.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS Volume: 12Issue: 2Pages: 145-154Published: MAR 2013

WOS
Cit.[4] Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trialBy: Zinkstok, Sanne M.; Roos, Yvo B.

Group Author(s): ARTIS Investigators

LANCET Volume: 380 Issue: 9843 Pages: 731-737 Published: AUG 25 2012

WOS
Cit.[5] 1 in Chinese Science Citation Database WOS
i[7]  JONSZTA, Tomáš, Martin KULIHA, Martin ROUBEC, R. HERZIG, D. ŠAŇÁK, Václav PROCHÁZKA a David ŠKOLOUDÍK. Endovascular treatment of acute ischemic stroke. In: New developments in angiography research. New York: Nova Science Publishers, 2012, S. 1-39. ISBN 978-1-62081-492-5.
Cit.[1] Vaško, P., Kožnar, B., Štětkářová, I., Peisker, T., Widimský, P.Acute stroke in a young healthy woman with hormonal contraception: Direct percutaneous thrombectomy with stent-retriever followed by full neurologic recovery(2013) Cor et Vasa, 55 (2), pp. E107-E110.  SCOPUS
Cit.[2] Školoudík, D., Kuliha, M., Jonszta, T., Herzig, R.Endovascular treatment of an ischemic cerebrovascular event [Endovaskulární léčba ischemické cévní mozkové příhody](2012) Ceska a Slovenska Neurologie a Neurochirurgie, 75 (6), pp. 669-683. SCOPUS
i[8]  JONSZTA, Tomáš, Daniel CZERNÝ, David ŠKOLOUDÍK, M. BÖHM,, P. KLEMENT a Václav PROCHÁZKA. EkoSonicSV endovascular system for recanalization of the basilar artery occlusion. VASA. 2011, vol. 40, no. 5, p. 408-413. ISSN 0301-1526. (1.308 – IF2011).
Cit.[1] Safety and efficacy of sonothrombolysis using bilateral TCD monitoring by diagnostic 2 MHz probes – a pilot studyBy: Bardon, Petr; Kuliha, Martin; Herzig, Roman; et al.

BIOMEDICAL PAPERS-OLOMOUC Volume: 158Issue: 2Pages: 233-237Published: 2014

WOS
Cit.[2] Intravascular Ultrasound: A Plus in the Management of Cerebral Venous Intravascular Problems?By: Raftopoulos, Christian

WORLD NEUROSURGERY Volume: 80Issue: 5Pages: 519-520Published: NOV 2013

WOS
i[9]  VÁVROVÁ, M., I. SLEZÁČEK, Petr VÁVRA, P. KARLOVÁ a Václav PROCHÁZKA. Pseudoaneurysm of the left internal carotid artery following tonsillectomy. VASA. 2011, vol. 40, no. 6, p. 491-494. ISSN 0301-1526.
Cit.[1] Windfuhr, J.P.Faults and failure of tonsil surgery and other standard procedures in otorhinolaryngology [Fehler und Gefahren: Tonsillektomie und andere Standard-Eingriffe] (2013) Laryngo- Rhino- Otologie, 92 (SUPPL.1), pp. S33-S72 SCOPUS
i[10]  ROUBEC, Martin, Martin KULIHA, Tomáš JONSZTA, Václav PROCHÁZKA, Táňa FADRNÁ, M. FILIP, P. KAŇOVSKÝ, K. LANGOVÁ, R. HERZIG a David ŠKOLOUDÍK. Detection of intracranial arterial stenosis using transcranial color-coded duplex sonography, computed tomographic angiography, and digital subtraction angiography. Journal of Ultrasound in Medicine. 2011, vol. 30, no. 8, p. 1069-1075. ISSN 0278-4297.
Cit.[1] Associations of high sensitivity C-reactive protein levels with the prevalence of asymptomatic intracranial arterial stenosisBy: Wang, J.; Liu, Y.; Zhang, L.; et al.

EUROPEAN JOURNAL OF NEUROLOGY Volume: 21Issue: 3Pages: 512-518Published: MAR 2014

WOS
Cit.[2] Association Between Ambulatory Systolic Blood Pressure During the Day and Asymptomatic Intracranial Arterial StenosisBy: Chen, Chao-Ting; Li, Yan; Zhang, Jin; et al.

HYPERTENSION Volume: 63Issue: 1Pages: 61-67Published: JAN 2014

WOS
Cit.[3] Double-barrel entanglement of intracranial Enterprise stents resulting from undetected incomplete stent appositionBy: Heller, Robert S.; Safain, Mina; Malek, Adel M.

JOURNAL OF NEUROINTERVENTIONAL SURGERY Volume: 4Issue: 6Article Number: e38Published: NOV 2012

WOS
Cit.[4] Current diagnosis and management of symptomatic intracranial atherosclerotic diseaseBy: Prabhakaran, Shyam; Romano, Jose G.

CURRENT OPINION IN NEUROLOGY Volume: 25Issue: 1Pages: 18-26Published: FEB 2012

WOS
Cit.[5] Flemming, K.D.Diagnosis of Stroke Mechanisms and Secondary Prevention(2013) Stroke, pp. 55-77. SCOPUS
Cit.[6] Caprio, F.Z., Prabhakaran, S.Advances in imaging of intracranial atherosclerotic disease and implications for treatment(2013) Current Treatment Options in Cardiovascular Medicine, 15 (3), pp. 335-347. SCOPUS
i[11]  BAR, Michal, P. SANDERCOCK, David ŠKOLOUDÍK a Václav PROCHÁZKA. Should mechanical embolectomy devices be used in routine clinical practice?. Journal of neural transmission. 2011, vol. 118, no. 8, p. 1131-1138. ISSN 0300-9564.
Cit.[1] Safety and Efficacy of Intravenous Thrombolytic Therapy of Cerebral Infarction in Patients over 80 Years of AgeBy: Petrovicsova, M.; Kadlecova, P.; Vaclavik, D.; et al.

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE Volume: 75Issue: 5Pages: 581-585Published: 2012

WOS
Cit.[2] Identification of Prognostic Factors for Thrombolytic Therapy in Patients with Acute Stroke – Analysis of the SITS RegistryBy: Bar, M.; Kadlecova, P.; Vaclavik, D.; et al.

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE Volume: 75Issue: 4Pages: 426-431Published: 2012

WOS
i[12]  BAR, Michal, David ŠKOLOUDÍK, Martin ROUBEC, Pavel HRADÍLEK, Jana CHMELOVÁ, Daniel CZERNÝ, Václav PROCHÁZKA, K. LANGOVÁ a R. HERZIG. Transcranial duplex sonography and CT angiography in acute stroke patients. Journal of neuroimaging. 2010, vol. 20, no. 3, p. 240-245. ISSN 1051-2284.
Cit.[1] The diagnostic accuracy of TCD for intracranial arterial stenosis/occlusion in patients with acute ischemic stroke: the importance of time interval between detection of TCD and CTABy: Guan, Jingxia; Zhou, Qin; Ouyang, Huangqing; et al.

NEUROLOGICAL RESEARCH Volume: 35Issue: 9Pages: 930-936Published: NOV 2013

WOS
Cit.[2] Knowledge of vascular status for therapeutic decision-making in acute ischemic stroke: which is the role of neurosonology?By: Garcia-Pastor, Andres

REVISTA DE NEUROLOGIA Volume: 56Issue: 1Pages: 35-42Published: JAN 1 2013

WOS
Cit.[3] Endovascular approaches for acute ischaemic stroke: the current evidence and organizational issuesBy: Kobayashi, Adam

POSTEPY W KARDIOLOGII INTERWENCYJNEJ Volume: 8Issue: 3Pages: 216-224Published: SEP 2012

WOS
Cit.[4] Safety and Efficacy of Intravenous Thrombolytic Therapy of Cerebral Infarction in Patients over 80 Years of AgeBy: Petrovicsova, M.; Kadlecova, P.; Vaclavik, D.; et al.

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE Volume: 75Issue: 5Pages: 581-585Published: 2012

WOS
Cit.[5] Schoysman, L., Tshibanda, J.-F., Otto, B., Sprynger, M., Nchimi, A.Transcranial color-coded sonography in the management of patients with cervical and intracranial arterial stenosis [L’écho-doppler transcrânien dans la prise en charge des sténoses artérielles cervicales et intracrâniennes](2014) Revue Medicale de Liege, 69 (3), pp. 146-150. SCOPUS
i[13]  CHMELOVÁ, Jana, Z. KOLÁŘ, Václav PROCHÁZKA, Romuald ČUŘÍK, Jana DVOŘÁČKOVÁ, Pavel ŠIRŮČEK, Otakar KRAFT a Tomáš HRBÁČ. Moyamoya disease is associated with endothelial activity detected by anti-nestin antibody. Biomedical papers. 2010, vol. 154, no. 2, p. 159-162. ISSN 1213-8118.
Cit.[1] Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesiaBy: Ohlin, K. Elisabet; Francardo, Veronica; Lindgren, Hanna S.; et al.

BRAIN Volume: 134Pages: 2339-2357Part: 8Published: AUG 2011

WOS
Cit.[2] High-Resolution Magnetic Resonance Wall Imaging Findings of Moyamoya DiseaseBy: Ryoo, Sookyung; Cha, Jihoon; Kim, Suk Jae; et al.

STROKE Volume: 45Issue: 8Pages: 2457-2460Published: AUG 2014

WOS
i[14]  PROCHÁZKA, Václav, Jaromír GUMULEC, František JALŮVKA, D. ŠALOUNOVÁ, Tomáš JONSZTA, Daniel CZERNÝ, Jan KRAJČA, René URBANEC, P. KLEMENT, J. MARTÍNEK a G. L. KLEMENT. Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell transplantation. 2010, vol. 19, no. 11, p. 1413-1424. ISSN 0963-6897.
Cit.[1] Role of adipose-derived stem cells in wound healingBy: Ul Hassan, Waqar; Greiser, Udo; Wang, Wenxin

WOUND REPAIR AND REGENERATION Volume: 22Issue: 3Pages: 313-325Published: MAY-JUN 2014

WOS
Cit.[2] Activity of mesenchymal stem cells in therapies for chronic skin wound healingBy: Nuschke, Austin

ORGANOGENESIS Volume: 10Issue: 1Pages: 29-37Published: JAN 1 2014

WOS
Cit.[3] Cancer Risk Is Not Increased in Patients Treated for Orthopaedic Diseases with Autologous Bone Marrow Cell ConcentrateBy: Hernigou, Philippe; Homma, Yasuhiro; Flouzat-Lachaniette, Charles-Henri; et al.

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME Volume: 95AIssue: 24Pages: 2215-2221Published: DEC 18 2013

WOS
Cit.[4] Autologous Bone Marrow-Derived Cell Therapy in Patients With Critical Limb Ischemia A Meta-Analysis of Randomized Controlled Clinical TrialsBy: Teraa, Martin; Sprengers, Ralf W.; van der Graaf, Yolanda; et al.

ANNALS OF SURGERY Volume: 258Issue: 6Pages: 922-929Published: DEC 2013

WOS
Cit.[5] Antibody-directed Double Suicide Gene Therapy Targeting of MUC1-Positive Leukemia Cells In Vitro and In VivoBy: Dong, Xiao-Ya; Wang, Wen-Qian; Zhao, Yu; et al.

CURRENT GENE THERAPY Volume: 13Issue: 5Pages: 346-357Published: OCT 2013

WOS
Cit.[6] POSTISCHEMIC REVASCULARIZATION: FROM CELLULAR AND MOLECULAR MECHANISMS TO CLINICAL APPLICATIONSBy: Silvestre, Jean-Sebastien; Smadja, David M.; Levy, Bernard I.

PHYSIOLOGICAL REVIEWS Volume: 93Issue: 4Pages: 1743-1802Published: OCT 2013

WOS
Cit.[7] Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatmentBy: Dubsky, M.; Jirkovska, A.; Bem, R.; et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS Volume: 29Issue: 5Pages: 369-376Published: JUL 2013

WOS
Cit.[8] Intra-arterial Autologous Bone Marrow Cell Transplantation in a Patient with Upper-extremity Critical Limb IschemiaBy: Madaric, Juraj; Klepanec, Andrej; Mistrik, Martin; et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY Volume: 36Issue: 2Pages: 545-548Published: APR 2013

WOS
Cit.[9] Gene Therapy and Cell-Based Therapies for Therapeutic Angiogenesis in Peripheral Artery DiseaseBy: Shimamura, Munehisa; Nakagami, Hironori; Koriyama, Hiroshi; et al.

BIOMED RESEARCH INTERNATIONAL Article Number: 186215Published: 2013

WOS
Cit.[10] Safety and Efficacy of Autologous Cell Therapy in Critical Limb Ischemia: A Systematic ReviewBy: Benoit, Eric; O’Donnell, Thomas F., Jr.; Patel, Amit N.

CELL TRANSPLANTATION Volume: 22Issue: 3Pages: 545-562Published: 2013

WOS
Cit.[11] Autologous bone marrow stem cell transplantation in critical limb ischemia: a meta-analysis of randomized controlled trialsBy: Liu Fu-peng; Dong Jian-jun; Sun Shu-juan; et al.

CHINESE MEDICAL JOURNAL Volume: 125Issue: 23Pages: 4296-4300Published: DEC 5 2012

WOS
Cit.[12] Peripheral blood mono-nuclear cells implantation in patients with peripheral arterial disease: a pilot study for clinical and biochemical outcome of neoangiogenesisBy: Amato, Bruno; Compagna, Rita; Della Corte, Gianni Antonio; et al.

BMC SURGERY Volume: 12Supplement: 1Article Number: S1Published: NOV 15 2012

WOS
Cit.[13] Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemiaBy: Kinoshita, Makoto; Fujita, Yasuyuki; Katayama, Minako; et al.

ATHEROSCLEROSIS Volume: 224Issue: 2Pages: 440-445Published: OCT 2012

 

WOS
Cit.[14] Concise Review: Therapeutic Potential of Adipose Tissue-Derived Angiogenic CellsBy: Szoke, Krisztina; Brinchmann, Jan E.

STEM CELLS TRANSLATIONAL MEDICINE Volume: 1Issue: 9Pages: 658-667Published: SEP 2012

WOS
Cit.[15] Painful black toe A case studyBy: Leung, Lawrence

AUSTRALIAN FAMILY PHYSICIAN Volume: 41Issue: 9Pages: 704-706Published: SEP 2012

WOS
Cit.[16] A Phase II Trial of Autologous Transplantation of Bone Marrow Stem Cells for Critical Limb Ischemia: Results of the Naples and Pietra Ligure Evaluation of Stem Cells StudyBy: Schiavetta, Alessandro; Maione, Ciro; Botti, Chiara; et al.

STEM CELLS TRANSLATIONAL MEDICINE Volume: 1Issue: 7Pages: 572-578Published: JUL 2012

WOS
Cit.[17] X-Ray-Visible Microcapsules Containing Mesenchymal Stem Cells Improve Hind Limb Perfusion in a Rabbit Model of Peripheral Arterial DiseaseBy: Kedziorek, Dorota A.; Hofmann, Lawrence V.; Fu, Yingli; et al.

STEM CELLS Volume: 30Issue: 6Pages: 1286-1296Published: JUN 2012

WOS
Cit.[18] Optimized Processing of Growth Factor Mobilized Peripheral Blood CD34+Products by Counterf low Centrifugal ElutriationBy: Tran, Chy-Anh; Torres-Coronado, Monica; Gardner, Agnes; et al.

STEM CELLS TRANSLATIONAL MEDICINE Volume: 1Issue: 5Pages: 422-429Published: MAY 2012

WOS
Cit.[19] Clinical Applications and Biosafety of Human Adult Mesenchymal Stem CellsBy: Mariani, E.; Facchini, A.

CURRENT PHARMACEUTICAL DESIGN Volume: 18 Issue: 13 Pages: 1821-1845 Published: MAY 2012

WOS
Cit.[20] Prospects for translational regenerative medicineBy: Chen, Fa-Ming; Zhao, Yi-Min; Jin, Yan; et al.

BIOTECHNOLOGY ADVANCES Volume: 30Issue: 3Pages: 658-672Published: MAY-JUN 2012

 

WOS
Cit.[21] No Difference in Intra-Arterial and Intramuscular Delivery of Autologous Bone Marrow Cells in Patients With Advanced Critical Limb IschemiaBy: Klepanec, Andrej; Mistrik, Martin; Altaner, Cestmir; et al.

CELL TRANSPLANTATION Volume: 21 Issue: 9 Pages: 1909-1918 Published: 2012

WOS
Cit.[22] The continued promise of stem cell therapy in regenerative medicineBy: Eve, David J.

MEDICAL SCIENCE MONITOR Volume: 17 Issue: 12 Pages: RA292-RA305 Published: DEC 2011

WOS
Cit.[23] Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemiaBy: Iafrati, Mark D.; Hallett, John W.; Geils, George; et al.

Conference: 37th Annual Meeting of the New-England-Society-for-Vascular-SurgeryLocation: Rockport, MEDate: SEP 23-26, 2010
Sponsor(s): New England Soc Vasc Surg

JOURNAL OF VASCULAR SURGERY Volume: 54Issue: 6Pages: 1650-1658Published: DEC 2011

WOS
Cit.[24] Autologous bone marrow cell therapy for patients with peripheral arterial disease: a meta-analysis of randomized controlled trialsBy: Wen, Yanting; Meng, Li; Gao, Qian

EXPERT OPINION ON BIOLOGICAL THERAPY Volume: 11Issue: 12Pages: 1581-1589Published: DEC 2011

WOS
Cit.[25] Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemiaBy: Powell, Richard J.; Comerota, Anthony J.; Berceli, Scott A.; et al.

Conference: Vascular Annual Meeting/Society-for-Vascular SurgeryLocation: Boston, MADate: JUN 10-13, 2010
Sponsor(s): Soc Vasc Surg

JOURNAL OF VASCULAR SURGERY Volume: 54 Issue: 4 Pages: 1032-1041 Published: OCT 2011

WOS
Cit.[26] The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial designBy: Benoit, Eric; O’Donnell, Thomas F., Jr.; Iafrati, Mark D.; et al.

JOURNAL OF TRANSLATIONAL MEDICINE Volume: 9Article Number: 165Published: SEP 27 2011

WOS
Cit.[27] The Use of Platelet-Rich Plasma in the Management of Foot and Ankle ConditionsBy: Jia, Xiaofeng; Peters, Paul G.; Schon, Lew

OPERATIVE TECHNIQUES IN SPORTS MEDICINE Volume: 19Issue: 3Pages: 177-184Published: SEP 2011

WOS
Cit.[28-29] 2 in Chinese Science Citation Database WOS
Cit.[30] Gupta, N.K., Armstrong, E.J., Parikh, S.A.The current state of stem cell therapy for peripheral artery dinase (2014) Current Cardiology Reports, 16 (2), . SCOPUS
Cit.[31] Konenkov, V.I., Klimontov, V.V.Gene and cell-based technologies for the treatment of diabetic foot syndrome(2014) Diabetes Mellitus, (1), pp. 63-69. SCOPUS
Cit.[32] Malyar, N.M., Radtke, S., Malyar, K., Arjumand, J., Horn, P.A., Kröger, K., Freisinger, E., Reinecke, H., Giebel, B., Brock, F.-E.Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters(2014) Cytotherapy, 16 (9), pp. 1270-1279. SCOPUS
Cit.[33] Yang, S.S., Kim, N.R., Park, K.B., Do, Y.S., Roh, K., Kang, K.S., Kim, D.I.A Phase I Study of Human Cord Blood-Derived Mesenchymal Stem Cell Therapy in Patients with Peripheral Arterial Occlusive Disease (2013) International Journal of Stem Cells, 6 (1), pp. 37-44. SCOPUS
Cit.[34] Botti, C., Maione, C., Coppola, A., Sica, V., Cobellis, G.Autologous bone marrow cell therapy for peripheral arterial dinase (2012) Stem Cells and Cloning: Advances and Applications, 5 (1), pp. 5-14. SCOPUS
Cit.[35] Casamassimi, A., Grimaldi, V., Infante, T., Al-Omran, M., Crudele, V., Napoli, C.Adult stem cells and the clinical arena: Are we able to widely use this therapy in patients with chronic limbs arteriopathy and ischemic ulcers without possibility of revascularization?(2012) Cardiovascular and Hematological Agents in Medicinal Chemistry, 10 (2), pp. 99-108. SCOPUS
Cit.[36] Battistella, V., De Freitas, G.R., Da Fonseca, L.M.B., Mercante, D., Gutfilen, B., Goldenberg, R.C.S., Vieira Dias, J., Kasai-Brunswick, T.H., Wajnberg, E., Rosado-De-Castro, P.H., Alves-Leon, S.V., Mendez-Otero, R., Andre, C.Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke(2011) Regenerative Medicine, 6 (1), pp. 45-52. SCOPUS
i[15]  KHORSANDI, S. E., P. KYSELA, V. VÁLEK, O.M.S. OLUFEMI, I. LÁZÁR, Václav PROCHÁZKA, D. ZACHAROULIS, C. ROUNTAS a N. A. HABIB. Initial data on a novel endovascular radiofrequency catheter when used for arterial occlusion in liver cancer. European surgery. 2009, vol. 41, no. 3, p. 104-108. ISSN 1682-8631.
Cit.[1] Management of Hepatocellular CarcinomaBy: Asham, Emad H.; Kaseb, Ahmed; Ghobrial, R. Mark

SURGICAL CLINICS OF NORTH AMERICA Volume: 93Issue: 6Pages: 1423-+Published: DEC 2013

WOS
Cit.[2] Old and still modern: the open minded approachBy: Riegler, F. M.

EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA Volume: 41 Issue: 3 Pages: 95-97 Published: JUN 2009

WOS
Cit.[3-5] 3 in Chinese Science Citation Database WOS
i[16]  PROCHÁZKA, Václav, Jaromír GUMULEC, Jana CHMELOVÁ, Petr KLEMENT, G. L. KLEMENT, Tomáš JONSZTA, Daniel CZERNÝ a Jan KRAJČA. Autologous Bone Marrow Stem Cell Transplantation in Patients with End-Stage Chronical Critical Limb Ischemia and Diabetic Foot. Vnitřní lékařství. 2009, vol. 55, no. 3, p. p. 173-178. ISSN 0042-773X.
Cit.[1] Park, S.A., Reilly, C.M., Wood, J.A., Chung, D.J., Carrade, D.D., Deremer, S.L., Seraphin, R.L., Clark, K.C., Zwingenberger, A.L., Borjesson, D.L., Hayashi, K., Russell, P., Murphy, C.J.Safety and immunomodulatory effects of allogeneic canine adipose-derived mesenchymal stromal cells transplanted into the region of the lacrimal gland, the gland of the third eyelid and the knee joint. (2013) Cytotherapy, 15 (12), pp. 1498-1510. SCOPUS
Cit.[2] Wan, J., Xia, L., Liang, W., Liu, Y., Cai, Q.Transplantation of bone marrow-derived mesenchymal stem cells promotes delayed wound healing in diabetic rats(2013) Journal of Diabetes Research, 2013, art. no. 647107. SCOPUS
Cit.[3] Li, Y., Zheng, L., Xu, X., Song, L., Li, Y., Li, W., Zhang, S., Zhang, F., Jin, H.Mesenchymal stem cells modified with angiopoietin-1 gene promote wound healing(2013) Stem Cell Research and Therapy, 4 (5), art. no. 113.  SCOPUS
Cit.[4] Botti, C., Maione, C., Coppola, A., Sica, V., Cobellis, G.Autologous bone marrow cell therapy for peripheral arterial disease(2012) Stem Cells and Cloning: Advances and Applications, 5 (1), pp. 5-14. SCOPUS
Cit.[5] Jiang, X.-Y., Lu, D.-B., Chen, B.Progress in stem cell therapy for the diabetic foot(2012) Diabetes Research and Clinical Practice, 97 (1), pp. 43-50. SCOPUS
Cit.[6] Kim, H., Kim, J.J., Yoon, Y.-s.Emerging therapy for diabetic neuropathy: Cell therapy targeting vessels and nerves(2012) Endocrine, Metabolic and Immune Disorders – Drug Targets, 12 (2), pp. 168-178. SCOPUS
Cit.[7] Blumberg, S.N., Berger, A., Hwang, L., Pastar, I., Warren, S.M., Chen, W.The role of stem cells in the treatment of diabetic foot ulcers. (2012) Diabetes Research and Clinical Practice, 96 (1), pp. 1-9. SCOPUS
Cit.[8] Elsharawy, M.A., Naim, M., Greish, S.Human CD34+ stem cells promote healing of diabetic foot ulcers in rats(2012) Interactive Cardiovascular and Thoracic Surgery, 14 (3), pp. 288-293. SCOPUS
Cit.[9] Larijani, B., Esfahani, E.N., Amini, P., Nikbin, B., Alimoghaddam, K., Amiri, S., Malekzadeh, R., Yazdi, N.M., Ghodsi, M., Dowlati, Y., Sahraian, M.A., Ghavamzadeh, A.Stem cell therapy in treatment of different diseases(2012) Acta Medica Iranica, 50 (2), pp. 79-96. SCOPUS
Cit.[10] Shoykhet, Ya.N., Khorev, N.G.Cell-based therapy for peripheral arterial diseases(2011) Cellular Transplantation and Tissue Engineering, 6 (3), pp. 15-23. SCOPUS
Cit.[11] Weck, M., Slesaczeck, T., Rietzsch, H., Münch, D., Nanning, T., Paetzold, H., Florek, H.-J., Barthel, A., Weiss, N., Bornstein, S.Noninvasive management of the diabetic foot with critical limb ischemia: Current options and future perspectives(2011) Therapeutic Advances in Endocrinology and Metabolism, 2 (6), pp. 247-255. SCOPUS
Cit.[12] Lawall, H., Bramlage, P., Amann, B.Treatment of peripheral arterial disease using stem and progenitor cell therapy(2011) Journal of Vascular Surgery, 53 (2), pp. 445-453. SCOPUS
Cit.[13] Dubský, M., Jirkovská, A., Bém, R., Pagácová, L., Fejfarová, V., Varga, M., Skibová, J., Langkramer, S., Syková, E.Treatment of critical limb ischemia and diabetic foot disease by the use of autologous stem cells [Terapie kritické končetinové ischemie u pacientů se syndromem diabetické nohy pomocí autologních kmenových buněk](2011) Vnitrni Lekarstvi, 57 (5), pp. 451-455. SCOPUS
Cit.[14] Zhang, Z.-Q., Zhang, J., Sun, H., Jiang, S., Zheng, Y.-D., Hu, S. Registered clinical studies of adult stem cells for non-malignant diseases(2011) Journal of Clinical Rehabilitative Tissue Engineering Research, 15 (1), pp. 120-125. SCOPUS
Cit.[15] Si, Y.-L., Zhao, Y.-L., Hao, H.-J., Fu, X.-B., Han, W.-D.MSCs: Biological characteristics, clinical applications and their outstanding concerns(2011) Ageing Research Reviews, 10 (1), pp. 93-103. SCOPUS
Cit.[16] Ma, Y., Chen, S., Bi, X.-J., Jiang, M.Mononuclear cells and platelets isolated from human bone marrow using hydroxyethyl starch by one-step way versus two-step way. (2010) Journal of Clinical Rehabilitative Tissue Engineering Research, 14 (40), pp. 7529-7532. SCOPUS
Cit.[17] Ulicna, M., Danisovic, L., Vojtassak, J.Does cell therapy and tissue engineering represent a promising treatment of diabetic foot ulcers?(2010) Bratislava Medical Journal, 111 (3), pp. 138-143. SCOPUS
Cit.[18] Meng, J., Yao, X., Kang, S., Kang, S., Yang, Y., Zhou, C.Treatment of ischemic limbs by transplantation of G-CSF stimulated bone marrow cells in diabetic rabbits(2010) Clinical and Investigative Medicine, 33 (3), pp. E174-E180. SCOPUS
Cit.[19] Bahk, J.Y., Jung, J.H., Han, H., Min, S.K., Lee, Y.S.Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: Preliminary report of 7 cases(2010) Experimental and Clinical Transplantation, 8 (2). SCOPUS
Cit.[20] Malý, R., Chovanec, V.Peripheral arterial disease and diabetes [Ischemická choroba dolních končetin a diabetes](2010) Vnitrni Lekarstvi, 56 (4), pp. 341-346. SCOPUS
Cit.[21] Lawall, H., Bramlage, P., Amann, B.Stem cell and progenitor cell therapy in peripheral artery disease: A critical appraisal(2010) Thrombosis and Haemostasis, 103 (4), pp. 696-709. SCOPUS
i[17]  ŠÍR, Milan, Václav PROCHÁZKA, Jaromír GUMULEC a Leopold PLEVA. Naše první zkušenosti s transplantací autologních kmenových buněk kostní dřeně v léčbě pakloubů, opožděného hojení zlomenin a defektních zlomenin dlouhých kostí. Vnitřní lékařství. 2009, roč. 55, č. 3, s. 187-189. ISSN 0042-773X
Cit.[1] Dubský, M., Jirkovská, A., Bem, R., Fejfarová, V., Pagáčová, L., Lesný, P., Syková, E.Stem cell therapy in patients with peripheral arterial disease and diabetic foot disease [Možnosti buněčné terapie ischemické choroby dolních končetin u syndromu diabetické nohy]. (2009) Diabetologie Metabolismus Endokrinologie Vyziva, 12 (3), pp. 128-132. SCOPUS
i[18]  GUMULEC, Jaromír, P. KESSLER, Václav PROCHÁZKA, M. BREJCHA, M. PENKA, M. ZÄNGER, Evžen MACHYTKA a Petr KLEMENT. Krvácivé komplikace antikoagulační léčby. Vnitřní lékařství. 2009, roč. 55, č. 3, s. 277-289. ISSN 0042-773X.
Cit.[1] Bauer, J. Novel anticoagulants in prevention of cardioembolic stroke in patiens with non-valvular atrial fibrillation [Nová antikoagulancia v prevenci kardioembolických iktů u pacientů s nevalvulární fibrilací síní]. (2013) Ceska a Slovenska Neurologie a Neurochirurgie, 76 (5), pp. 550-558. SCOPUS
Cit.[2] Vasilyev, S.A., Vinogradov, V.L., Gemdzhyan, E.G.The problem of hemorrhagic syndrome in its treatment with vitamin K antagonists (a review of literature)(2012) Terapevticheskii Arkhiv, 84 (7), pp. 89-94. SCOPUS
Cit.[3] Kessler, M.P.How to prepare a patient treated with warfarin for surgery? [Jak připravit pacienta léčeného warfarinem k operaci?](2012) Interni Medicina pro Praxi, 14 (4), pp. 173-176. SCOPUS
Cit.[4] Bauer, J. Prevention of cardioembolic stroke [Prevence kardioembolických cévních mozkových příhod](2012) Interni Medicina pro Praxi, 14 (1), pp. 26-29. SCOPUS
Cit.[5] Bauer, J. Anticoagulant therapy in the prevention and treatment of ischemic stroke [Antikoagulační terapie v prevenci a léč bě ischemických iktů](2010) Ceska a Slovenska Neurologie a Neurochirurgie, 73 (5), pp. 480-491. SCOPUS
i[19]  JONSZTA, Tomáš, Václav PROCHÁZKA, Daniel CZERNÝ, Michaela VÁVROVÁ a Jana CHMELOVÁ. Detection of dural ectasia in diagnosis of Marfan´s syndrome. VASA. 2008, vol. 37, no. 4, p. 364-370. ISSN 0301-1526. (0.564 – IF2008).
Cit.[1] Dural ectasia in individuals with Marfan-like features but exclusion of mutations in the genes FBN1, TGFBR1 and TGFBR2By: Sheikhzadeh, S.; Rybczynski, M.; Habermann, C. R.; et al.

CLINICAL GENETICS Volume: 79Issue: 6Pages: 568-574Published: JUN 2011

WOS
Cit.[2] Spinal imaging contributes to the diagnosis of Marfan syndromeBy: Sznajder, Marc; Krug, Pauline; Taylor, Melissa; et al.

JOINT BONE SPINE Volume: 77Issue: 5Pages: 445-450Published: OCT 2010

 

WOS
Cit.[3] Sznajder, M., Krug, P., Taylor, M., Moura, B., Leparc, J.-M., Boileau, C., Jondeau, G., Chevallier, B., Pelage, J.-P., Stheneur, C. Spinal imaging contributes to the diagnosis of Marfan syndrome [L’imagerie du rachis contribue au diagnostic de syndrome de Marfan](2010) Revue du Rhumatisme (Edition Francaise), 77 (5), pp. 495-500.  SCOPUS
Cit.[4] Von Kodolitsch, Y., Rybczynski, M., Bernhardt, A., Mir, T.S., Treede, H., Dodge-Khatami, A., Robinson, P.N., Sheikhzadeh, S., Reichenspurner, H., Meinertz, T.Marfan syndrome and the evolving spectrum of heritable thoracic aortic disease: Do we need genetics for clinical decisions? (2010) Vasa – Journal of Vascular Diseases, 39 (1), pp. 17-32. SCOPUS
i[20]  PROCHÁZKA, M., Václav PROCHÁZKA, M. LUBUŠKÝ, J. PROCHÁZKOVÁ a Tomáš HRBÁČ. Mozková žilní trombóza u uživatelek hormonální antikoncepce. Česká a slovenská neurologie a neurochirurgie. 2007, roč. 70/103, č. 6, s. 678-684. ISSN 1210-7859.  
Cit.[1] Cerebral Venous Thrombosis – Analysis of a Consecutive Series of 33 PatientsBy: Krajickova, D.; Kostal, M.; Krajina, A.; et al.

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE Volume: 73 Issue: 4 Pages: 402-408 Published: 2010

 

WOS
i[21]  VÁVROVÁ, Michaela, Václav PROCHÁZKA, Daniel CZERNÝ, Tomáš JONSZTA a Tamara LHOŤANOVÁ. May-Thurnerův syndrom v dětském věku. Česká radiologie. 2007, roč. 61, č. 4, s. 427-430. ISSN 1210-7883.   
Cit.[1] Hofírek, I., Penka, M., Zvarová, M., Šárník, S., Blatný, J., Zapletal, O., Rotnágl, J., Sochor, O. Local intravenous fibrinolysis in children and adolescents [Lokální intravenózní fibrinolýza u dětí a mladistvých]. (2010) Vnitrni Lekarstvi, 56 (SUPPL. 1), pp. S58-S63. SCOPUS
i[22]  MĚCHUROVÁ, A. a Václav PROCHÁZKA. Spontaneous Spinal Epidural Haematoma at C 5-Th 7 Level after Spontaneous Delivery. Rivista di Neuroradiologica. 2006, vol. 19, no. 2, p. 169-175. ISSN 1120-9976.
Cit.[1] Henry, J.B., Messerer, M., Thomas, V., Diabira, S., Morandi, X., Hamlat, A.Nontraumatic spinal epidural hematoma during pregnancy: Diagnosis and management concerns(2012) Spinal Cord, 50 (9), pp. 655-660. SCOPUS
i[23]  PROCHÁZKA, Václav, Tomáš HRBÁČ, Jana CHMELOVÁ, David ŠKOLOUDÍK a M. PROCHÁZKA. PHACE Syndrome: Persistent Fetal Vascular Anomalies. A Case Report. Interventional neuroradiology. 2005, vol. 11, no. 4, p. 355-361. ISSN 1123-9344.  
Cit.[1] A 65-Year-Old Woman Diagnosed With PHACE SyndromeBy: Burch, Ezra A.; Garzon, Maria C.; Parikh, Anuraag; et al.

PEDIATRIC DERMATOLOGY Volume: 30Issue: 6Pages: E153-E156Published: NOV 2013

 

WOS